New and Noteworthy in March

Upcoming Appearances

March 14^th: Dan Ollendorf, PhD, ICER’s Chief Scientific Officer, will speak at the Whither US Health Economic Evaluation Multi-Stakeholder Symposium in Morristown, NJ.

March 22^nd: Steven Pearson, MD, MSc, ICER’s President, will present on “Options for a Value-Based Formulary for the VA” to the VA Pharmacy Group in Chicago, IL.

March 30^th: Sarah Emond, MPP, ICER’s Executive Vice President and Chief Operating Officer, will speak on a panel titled “Innovation in Pharmacy Delivery: Value-Based Purchasing for Drugs” at the National Business Group on Health: Business Health Agenda 2017 Conference in Washington, D.C.

---

Key Dates

On or about March 6, 2017:  Final Evidence Report and Meeting Summary on Treatments for Multiple Sclerosis

March 6, 2017: Draft Scoping Document on Ovarian Cancer

March 6, 2017-March 27, 2017: Public Comments on Ovarian Cancer Scoping Document

March 10, 2017: Evidence Report on Treatments for Rheumatoid Arthritis

March 24, 2017: Public Meeting of New England CEPAC on Rheumatoid Arthritis

March 24, 2017: Draft Evidence Report on Treatments for Atopic Dermatitis